These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38169111)

  • 1. Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor.
    Meier-Abt F; Kraemer D; Braun N; Reinehr M; Stutz-Grunder E; Steindl K; Rauch A
    Am J Med Genet A; 2024 Jun; 194(6):e63528. PubMed ID: 38169111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-hit mutation causes Wilms tumor in an individual with FBXW7-related neurodevelopmental syndrome.
    Saito Y; Keino D; Kuroda Y; Enomoto Y; Naruto T; Tanaka Y; Tanaka M; Usui H; Kitagawa N; Yanagimachi M; Kurosawa K
    J Hum Genet; 2024 Oct; ():. PubMed ID: 39414990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.
    Stephenson SEM; Costain G; Blok LER; Silk MA; Nguyen TB; Dong X; Alhuzaimi DE; Dowling JJ; Walker S; Amburgey K; Hayeems RZ; Rodan LH; Schwartz MA; Picker J; Lynch SA; Gupta A; Rasmussen KJ; Schimmenti LA; Klee EW; Niu Z; Agre KE; Chilton I; Chung WK; Revah-Politi A; Au PYB; Griffith C; Racobaldo M; Raas-Rothschild A; Ben Zeev B; Barel O; Moutton S; Morice-Picard F; Carmignac V; Cornaton J; Marle N; Devinsky O; Stimach C; Wechsler SB; Hainline BE; Sapp K; Willems M; Bruel AL; Dias KR; Evans CA; Roscioli T; Sachdev R; Temple SEL; Zhu Y; Baker JJ; Scheffer IE; Gardiner FJ; Schneider AL; Muir AM; Mefford HC; Crunk A; Heise EM; Millan F; Monaghan KG; Person R; Rhodes L; Richards S; Wentzensen IM; Cogné B; Isidor B; Nizon M; Vincent M; Besnard T; Piton A; Marcelis C; Kato K; Koyama N; Ogi T; Goh ES; Richmond C; Amor DJ; Boyce JO; Morgan AT; Hildebrand MS; Kaspi A; Bahlo M; Friðriksdóttir R; Katrínardóttir H; Sulem P; Stefánsson K; Björnsson HT; Mandelstam S; Morleo M; Mariani M; ; Scala M; Accogli A; Torella A; Capra V; Wallis M; Jansen S; Weisfisz Q; de Haan H; Sadedin S; ; Lim SC; White SM; Ascher DB; Schenck A; Lockhart PJ; Christodoulou J; Tan TY
    Am J Hum Genet; 2022 Apr; 109(4):601-617. PubMed ID: 35395208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new Wilms tumour predisposition genes: an exome sequencing study.
    Mahamdallie S; Yost S; Poyastro-Pearson E; Holt E; Zachariou A; Seal S; Elliott A; Clarke M; Warren-Perry M; Hanks S; Anderson J; Bomken S; Cole T; Farah R; Furtwaengler R; Glaser A; Grundy R; Hayden J; Lowis S; Millot F; Nicholson J; Ronghe M; Skeen J; Williams D; Yeomanson D; Ruark E; Rahman N
    Lancet Child Adolesc Health; 2019 May; 3(5):322-331. PubMed ID: 30885698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
    Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
    Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number variants at 4q31.3 affecting the regulatory region of FBXW7 associated with neurodevelopmental delay.
    Zhou W; Wang C; Fu L; Shi W; Zhang A; Jia Z; Zhao X; Fu D; Zheng B
    Clin Genet; 2024 Sep; 106(3):354-359. PubMed ID: 38780184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
    J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
    Stoltze UK; Hildonen M; Hansen TVO; Foss-Skiftesvik J; Byrjalsen A; Lundsgaard M; Pignata L; Grønskov K; Tumer Z; Schmiegelow K; Brok JS; Wadt KAW
    J Med Genet; 2023 Sep; 60(9):842-849. PubMed ID: 37019617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM28 haploinsufficiency predisposes to Wilms tumor.
    Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
    Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
    Fiala EM; Ortiz MV; Kennedy JA; Glodzik D; Fleischut MH; Duffy KA; Hathaway ER; Heaton T; Gerstle JT; Steinherz P; Shukla N; McNeer N; Tkachuk K; Bouvier N; Cadoo K; Carlo MI; Latham A; Dubard Gault M; Joseph V; Kemel Y; Kentsis A; Stadler Z; La Quaglia M; Papaemmanuil E; Friedman D; Ganguly A; Kung A; Offit K; Kalish JM; Walsh MF
    Cancer; 2020 Jul; 126(13):3114-3121. PubMed ID: 32320050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant-A first report.
    Whitworth J; Armstrong R; Maher ER
    Eur J Hum Genet; 2024 Mar; 32(3):361-364. PubMed ID: 38282073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant.
    Falcone MP; Pritchard-Jones K; Brok J; Mifsud W; Williams RD; Nakata K; Tugnait S; Al-Saadi R; Side L; Anderson J; Duncan C; Marks SD; Bockenhauer D; Chowdhury T
    Pediatr Nephrol; 2022 Apr; 37(4):821-832. PubMed ID: 34608521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.
    Halliday BJ; Fukuzawa R; Markie DM; Grundy RG; Ludgate JL; Black MA; Skeen JE; Weeks RJ; Catchpoole DR; Roberts AGK; Reeve AE; Morison IM
    PLoS Genet; 2018 Jun; 14(6):e1007399. PubMed ID: 29912901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel CTR9 germline mutation in a family with Wilms tumor.
    Martins AG; Pinto AT; Domingues R; Cavaco BM
    Eur J Med Genet; 2018 May; 61(5):294-299. PubMed ID: 29292210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 gene analysis in sporadic early-onset and bilateral wilms tumor patients without associated abnormalities.
    Perotti D; Mondini P; Terenziani M; Spreafico F; Collini P; Fossati-Bellani F; Radice P
    J Pediatr Hematol Oncol; 2005 Apr; 27(4):197-201. PubMed ID: 15838390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of Xp22.11 Duplication as a Germline Susceptibility Alteration in a Wilms Tumor Arising in Horseshoe Kidney.
    Zhou HF; Amarillo IE; Snyder S; Granadillo JL; O'Conor CJ; Dillon P; Wilson D; Huang FS; Dehner LP; He M
    Fetal Pediatr Pathol; 2022 Aug; 41(4):682-688. PubMed ID: 33960268
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
    Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
    Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
    Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
    Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
    J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM28 variants and Wilms' tumour predisposition.
    Hol JA; Diets IJ; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MC; Kuiper RP
    J Pathol; 2021 Jul; 254(4):494-504. PubMed ID: 33565090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.